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Nuclear magnetic resonanceThe p7 protein from hepatitis C virus and the Vpu protein from HIV-1 are members of the viroporin family of
small viral membrane proteins. It is essential to determine their structures in order to obtain an
understanding of their molecular mechanisms and to develop new classes of anti-viral drugs. Because they
are membrane proteins, it is challenging to study them in their native phospholipid bilayer environments by
most experimental methods. Here we describe applications of NMR spectroscopy to both p7 and Vpu.
Isotopically labeled p7 and Vpu samples were prepared by heterologous expression in bacteria, initial
isolation as fusion proteins, and ﬁnal puriﬁcation by chromatography. The puriﬁed proteins were studied in
the model membrane environments of micelles by solution NMR spectroscopy and in aligned phospholipid
bilayers by solid-state NMR spectroscopy. The resulting structural ﬁndings enable comparisons to be made
between the two proteins, demonstrating that they have quite different architectures. Most notably, Vpu has
one trans-membrane helix and p7 has two trans-membrane helices; in addition, there are signiﬁcant
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1.1. Viroporins
Viroporins are relatively small viral membrane proteins whose
functions are crucial to the lifecycle of viruses [1,2]. Proteins classiﬁed
as viroporins include Vpu from the Human immunodeﬁciency virus 1
555G.A. Cook et al. / Biochimica et Biophysica Acta 1808 (2011) 554–560(HIV-1), p7 from Hepatitis C virus (HCV), M2 from the inﬂuenza virus
A, poliovirus 2B, and alphavirus 6K. Although these proteins are not
involved in replication, they appear to have multiple biological
activities, and are essential for viral infectivity by promoting virus
release. Structural investigations of viroporins are at an early stage,
with M2 from inﬂuenza being the most advanced [3–5]. However our
NMR studies of Vpu [6–14] and of p7 [15–17] have revealed many of
their principal structural features in membrane environments, and
the properties of these two proteins are compared here. In general, all
of the viroporins have several common features, including at least one
hydrophobic trans-membrane helix and conserved basic and/or
aromatic residues. There is evidence that at least some of these
proteins oligomerize to form ion channels [18–21], several of which
are inhibited by the addition of established channel blocking
compounds [21–27]. Also, mutations in these proteins can lead to
non-viable viruses [28–31]. These proteins are highly conserved
across genotypes, and these experimental results suggest that they
are potential targets for anti-viral drugs.
1.2. Viroporin proteins p7 of HCV and Vpu of HIV-1
Hepatitis C virus, a member of the Flaviviridae family, infects over
170 million people worldwide. Infections are often chronic, resulting
in cirrhosis, end-stage liver disease and hepatocellular carcinoma.
HCV's viral RNA, which is 2.6 kb, encodes a single polyprotein that is
proteolytically cleaved into ten proteins that are responsible for the
functions of the virus life cycle [32,33]. One of these proteins, p7, a
small hydrophobic protein with 63 residues, has been shown to play a
role in the release of mature virus particles from infected cells [28].
Topology predictions suggest that p7 has two hydrophobic trans-
membrane helices connected by a short inter-helical loop that
contains the two highly conserved basic residues, K33 and R35 [34–
36]. p7 has been shown to form hexamers in phospholipid bilayers,
and several groups have demonstrated that the resulting ion channels
can be blocked by compounds such as amantadine [21], hexamethy-
lene amiloride [23] and long acyl-chain iminosugar derivatives [24].
Human Immunodeﬁciency Virus (HIV) is a lentivirus in the
retrovirus family. HIV can lead to the acquired immune deﬁciency
syndrome (AIDS) by destroying crucial immune functions. In 2008, an
estimated 33.4 million people were infected with HIV worldwide.
HIV-1 and HIV-2 are the two principal types of HIV; HIV-1 is more
virulent, has higher infectivity, and contains the gene for Vpu. Vpu is
an 81-residuemembrane protein that is responsible for two biological
activities that contribute to the pathogenicity of HIV-1 infections in
humans; it accelerates the degradation of CD4 receptors and enhances
the release of newly formed virus particles from infected cells [37–
40]. These activities are associated with separate domains of the
protein. The C-terminal cytoplasmic domain of the protein modulates
CD4 degradation via the phosphorylation of two conserved serine
residues (S52 and S56). The N-terminal transmembrane domain is
responsible for enhancing the release of virus particles. The
mechanism by which Vpu enhances virus release is under active
investigation in a number of laboratories [18,41–44]. The results of
molecular dynamics simulations and channel activity studies have
shown that the hydrophobic transmembrane domain of Vpu can form
pentamers or tetramers [45]. Notably, a single mutation of alanine at
position 18 of Vpu by a histidine (A18H) has been shown to make the
virus infection sensitive to rimantadine, a M2 channel blocker [14].
1.3. Applications of NMR spectroscopy to p7 and Vpu
Information about the structure and dynamics of these proteins has
the potential to provide insights into their mechanisms of action and
contribute to the rational design of drugs. NMR spectroscopy can be
used to characterize the structure of these proteins at atomic resolution
in micelle and bilayer environments [14,46–48], something that is notpossible using other experimental methods of protein structure
determination. Another advantage of NMR spectroscopy is that
experiments are available that can be used to monitor molecular
motions on multiple timescales to provide a detailed description of the
dynamics of the proteins. Recent developments in instrumentation,
speciﬁcally, the design and construction of solid-state NMR probes that
reduce the sample heating due to high frequency radiofrequency
irradiations andprovidehigher sensitivity facilitate the studyof samples
with high dielectric constants like viroporins in their native environ-
ments of fully hydrated phospholipid bilayers [49].
2. Expression, isotopic labeling, and puriﬁcation of p7 and Vpu
2.1. Fusion protein expression
The over expression of polypeptides with sequences corresponding
to those of p7 and Vpu in bacteria is challenging because in high
concentrations they can disrupt the integrity of cell membranes,
resulting in the early death of rapidly growing bacteria. The use of
fusion proteins overcomes this obstacle, since the over expressed fusion
proteins are generally not toxic to bacteria because they are sequestered
in inclusion bodies, which keeps them away from the vulnerable cell
membranes. Fusion partner proteins such as Trp-leader (TrpΔLE) and
ketosteroid isomerase (KSI) are commonly used, and have been
successfully employed in the bacterial expression of p7 and Vpu.
The methods used for the expression and puriﬁcation for p7 and
Vpu have evolved from those previously described by Park et al. [10]
and by Cook et al. [15]. Coding sequences corresponding to p7 from
HCV genotype J4 and to Vpu from HIV-1 genotype NL43 were
designed with codon optimization to facilitate heterologous expres-
sion in Escherichia coli. Ampliﬁed sequences were inserted into
plasmid vectors containing N-terminal fusion proteins. The p7
sequence was fused to that of TrpΔLE and that of Vpu to KSI. Both
constructs include histidine tags to enable facile puriﬁcation by nickel
afﬁnity chromatography. The plasmids were transformed into BL21
(DE3) cells. Protein expression was induced by the addition of
isopropyl-β-D-thiogalactopyranoside (IPTG) when the growth media
reached an optical density of 0.5–0.6. Cells were allowed to grow an
additional 4–6 h and then harvested by centrifugation. The expression
of the fusion proteins is visualized in the SDS-PAGE shown in Fig. 1A
and D, where the total cell proteins before and after 4 hours of
induction by the addition of IPTG are compared.
2.2. Isotopic labeling
NMR experiments require milligram quantities of highly puriﬁed
isotopically labeled proteins. The expression of membrane proteins
as fusion proteins in E. coli can be carried out in a variety of media for
this purpose. M9 minimal media with 15N–ammonium sulfate, 13C-
glucose and/or deuterium oxide can be used to produce uniformly
15N, 13C and 2H-labeled proteins as required. M9 media can also be
prepared with speciﬁc isotopically labeled amino acids along with
other unlabeled amino acids to produce selectively labeled (by
residue type) proteins.
2.3. Puriﬁcation
Following expression in E. coli, the puriﬁcation of the polypeptides
is accomplished in several discrete steps. Following the disruption of
the cells, the fusion proteins are separated from soluble proteins and
membrane fractions using a detergent-containing resuspension
buffer. A denaturing buffer containing guanidine hydrochloride is
then used to solubilize the fusion proteins. Metal afﬁnity column with
nickel is used to separate the fusion protein from contaminants in the
inclusion bodies. To separate the polypeptide sequence of interest
from its fusion partner, site-speciﬁc cleavage is accomplished either as
Fig. 1. The expression and puriﬁcation of p7 and Vpu as fusion proteins in E. coli strain BL21 (DE3). (A–F) SDS-PAGE analysis. (A–B) p7. (D–F) Vpu. (A) The expression of His6-TrpLE-
p7. Left lane: protein size markers. Middle lane: total cell protein before induction. Right lane: total cell protein after induction with IPTG. The over expressed fusion protein is
marked with an arrow. (B) The puriﬁcation of p7 by size exclusion FPLC. Pure p7 is marked with an arrow in the rightmost lane. (D) The expression of KSI-Vpu. Left lane: protein size
markers. Middle lane: total cell protein before induction. Right lane: total cell protein after induction. Pure Vpu is marked with an arrow. (E) For the puriﬁcation of Vpu samples from
the HPLC injection solvent test are shown in an SDS-PAGE gel (lane 2 shows pre-cleaved protein while lanes 3 and 4 show that the protein aggregates in a typical HPLC solvent, TFE/
H2O/TFA, and in a more hydrophobic solvent, HFIP/H2O/TFA. (F) HPLC puriﬁed Vpu is marked with an arrow. The mass spectra of both proteins show that the puriﬁed proteins have
the correct mass. (C) p7 at 6766.00 Daltons. (G) Vpu at 9179.70 Daltons.
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thrombin or enterokinase, or chemical cleavage using a chemical
reagent such as cyanogen bromide. Final puriﬁcation of the protein is
generally accomplished with reverse-phase high performance liquid
chromatography (HPLC), as well as ion-exchange chromatography
and size exclusion chromatography as necessary.
Speciﬁcally, we utilize a four-step protocol for the puriﬁcation of
p7 and Vpu. Cell pellets are resuspended in resuspension buffer and
disrupted by sonication. Inclusion bodies are isolated by centrifuga-
tion and denatured in binding buffer containing Tris and 6M
guanidine prior to puriﬁcation by nickel afﬁnity chromatography.
The fusion protein is bound to the column, and after several wash
steps is eluted with guanidine-containing buffer containing a higher
concentration of imidazole; it is dialyzed to remove the denaturing
guanidine, and lyophilized to yield a dry powder. The protein is then
dissolved in 70% formic acid for cleavage by cyanogen bromide at a
methionine residue located between the sequence of the target
protein and its fusion partner. After neutralization and complete
removal of cyanogen bromide by dialysis, the protein is lyophilized.
The ﬁnal puriﬁcation step is performed by size exclusion fast protein
liquid chromatography (FPLC) for p7 and by reverse phase high
performance liquid chromatography (HPLC) on a C4 column for Vpu.
Samples of cleaved p7 and the FPLC elutions were subjected to SDS-
PAGE; the last lane in Fig. 1B contains pure p7 protein. For Vpu the
SDS-PAGE showing the solubilization of the protein in an organic
solvent prior to puriﬁcation by HPLC is in Fig. 1E. The sample tends to
aggregate in the typical HPLC solvent of triﬂuoroethanol (TFE), waterand triﬂuoroacetic acid (TFA) (50:49.9:0.1%) in lane 3, but was
completely dissolved when the loading solvent contained hexaﬂuor-
oisopropanol (HFIP)/water/TFA (50:49.9:0.1%) as shown in lane 4.
Mass spectrometry was used to conﬁrm the identity of the puriﬁed
proteins. The spectra show single peaks corresponding to the correct
masses for p7 (Fig. 1C) and Vpu (Fig. 1G). p7 appears as a monomer of
apparent molecular weight of ~7 kDa in the SDS-PAGE, in contrast,
Vpu appears as an oligomer of ~35 kDa, suggesting that Vpu is
oligomeric in the SDS micellar environment.3. Lipid environments for membrane proteins
3.1. Micelles, isotropic bicelles, and aligned bilayers
Micelles and isotropic bicelles can be used to study small
membrane proteins by solution NMR spectroscopy. They are
shown in cartoon form in Fig. 2A and B, respectively. Although not
ideal as a membrane environment because of the absence of a
bilayer, the small size of protein-containing micelles provide a
hydrophobic environment similar to that of a membrane that is
capable of undergoing overall reorientation fast enough to yield
solution NMR spectra with relatively narrow linewidths. The most
commonly used micelle-forming detergents and lipids are SDS
(sodium dodecyl sulfate), DPC (dodecylphosphocholine) and DHPC
(1,2-dihexanoyl-sn-glycero-3-phosphocholine). Many other mi-
celle-forming lipids and detergents are typically surveyed in the
Fig. 2. Cartoon representations of the phospholipid assemblies in the various NMR samples. (A) Micelles that consist of detergents or short chain lipids. (B) Isotropic bicelles that
consist of a mixture of long and short chain lipids with a qb1.0. (C) Magnetically aligned bilayers with q=3.2. Defects are shown in the bilayers.
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bicelles are prepared by the addition of small amounts of long chain
lipids like DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine) to
the micelle samples, typically with DHPC as the short chain lipid.
Bicelles are characterized by the molar ratio of long chain to short
chain lipids (q). For qb1, the rotational correlation times of small
membrane proteins are typically short enough to enable solution
NMR experiments.
Solid-state NMR spectroscopy provides the opportunity to study
membrane proteins in their native environment of fully hydrated
phospholipid bilayers under physiological conditions. This is a
signiﬁcant advantage over other experimental methods, but it
requires greater technical sophistication in the instrumentation
and experimental methods. In high-resolution solid-state NMR
experiments, intense radiofrequency irradiations replace rapid
molecular motions as the principal line-narrowing mechanism.
Two approaches are most commonly employed, either oriented
sample (OS) solid-state NMR of membrane proteins in aligned
bilayers or magic angle spinning (MAS) solid-state NMR of
unoriented samples. In general, magnetic alignment of bilayers
consisting of DMPC and DHPC with a q=3.2 provides convenient
samples for high-resolution solid-state NMR experiments. A sche-
matic drawing of the aligned bilayers is shown in Fig. 2C. The bilayers
self-assemble and align with their normals perpendicular to the
direction of the applied magnetic ﬁeld, which induces alignment of
the incorporated membrane protein [50–52]. The bilayers can be
“ﬂipped” with the addition of lanthanides or the use of biphenyl
lipids to provide an alignment of the bilayers with their normals
parallel to the magnetic ﬁeld [53]. As part of the sample optimization
process, a variety of additional lipids are incorporated in order to
improve the resolution of the spectra or stabilize the samples; these
include lipids with charged head groups, different acyl-chain
lengths, ester or ether linkages, and various sites of unsaturation.3.2. Sample preparations
It is crucial that the proteins used in the NMR experiments are
highly puriﬁed in order to have homogeneous samples and avoid
spurious signals. This requires the complete removal of denaturants,
organic solvents, and any unwanted detergents or lipids. This also
requires careful optimization of all sample conditions (pH, temper-
ature, and buffer and salt concentrations, etc.). Careful attention must
be paid during the solubilization of the protein with detergents or
lipids in order to ensure that the sample is completely clear and
homogeneous, and that the protein is fully solubilized and properly
folded. This is often done by adding a concentrated amount of the
detergent or lipid prior to diluting it for the ﬁnal sample. For solid-
state NMR the sample is put through a number of heat/cold/vortexing
cycles until the sample is clear, and displays the properties of a
magnetically alignable bilayer phase. Preliminary one-dimensional
NMR spectra are obtained to determine whether the sample is ready
for more detailed investigations.4. Solution NMR spectroscopy
4.1. Structure and dynamics
Following sample optimization, well-resolved, two-dimensional
1H-15N heteronuclear single quantum correlation (HSQC) solution
NMR spectra of uniformly 15N-labeled p7 (Fig. 3A) and Vpu
(Fig. 3E) were obtained in DHPC micelles. The complete backbone
resonance assignments of p7 and Vpu were obtained using
standard methods that included triple resonance experiments of
uniformly 15N and 13C labeled samples, two- and three-dimen-
sional homonuclear 1H/1H NOE experiments, and comparisons
among spectra of selectively labeled (by residue type) samples
[54,55]. The sequential resonance assignments are an essential
prerequisite to the spectroscopic measurements used to charac-
terize the secondary structure and internal dynamics of the
proteins. The chemical shift frequencies of several sites in the
amino acid residues (13CO, 13Cα, 1Hα or 13Cβ) are valuable data.
Deviations from the random coil values of the chemical shift index
(CSI) are suggestive of the secondary structure and can be used to
estimate the bond angles in the protein backbone [56].
Deuterium/hydrogen fractionation is an effective method for
identifying the basic topology of membrane proteins in micelles by
monitoring the relative facility for hydrogen exchange at backbone
amide sites [57]. With an increasing percentage of D2O in the solution,
the intensities of resonances in solvent accessible loop and terminal
regions are reduced compared to those in hydrophobic trans-
membrane helices. Heteronuclear 1H-15N NOEmeasurements provide
a reliable guide to differences in the local dynamics of membrane
proteins [58], since it is generally possible to distinguish qualitatively
between structured helical regions, and mobile loops, and terminal
regions. Bicelle q titration experiments can also be used to probe the
dynamics of a protein. By increasing the q of the protein-containing
bicelles, the overall reorientation rate of the protein is decreased,
causing the selective broadening of signals of those residues that are
structured within the bicelle environment. Fig. 3 demonstrates the
effect of increasing q on the spectra of uniformly 15N labeled p7 and
Vpu. Notably, essentially all of the signals are broadened beyond
detection in q=3.2 samples where both proteins are immobilized in
the bilayers and aligned in the magnetic ﬁeld. These samples are
suitable only for solid-state NMR experiments.
Paramagnetic relaxation enhancement (PRE) measurements are
increasingly being used to measure relatively long-range distances
between residues in proteins [59,60]. Site-directed mutagenesis
enables the attachment of electron spin labels such as a nitroxide
groups to speciﬁc sites where a cysteine is located. The paramagnetic
form of the label causes selective broadening of the resonances from
proximate residues that can be measured and converted into
quantitative distance constraints for structure calculations. The
reduced form of the label serves as the control. The results of these
experiments complement the angular restraints associated with
heteronuclear residual dipolar couplings (RDCs) to calculate the
three-dimensional structures of the proteins.
Fig. 3. Two-dimensional 1H/15N HSQC solution NMR spectra of uniformly 15N labeled p7 and Vpu in micelles, isotropic bicelles, and magnetically aligned bilayers obtained at 50 °C.
Top row: spectra of p7. (A) q=0 DHPC micelles. (B) q=0.1 bicelles. (C) q=0.5 bicelles. (D) q=3.2 bilayers. Bottom row: spectra of Vpu. (E) q=0 DHPC micelles. (F) q=0.25
bicelles. (G) q=1.0 bicelles. (H) q=3.2 bilayers.
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It is difﬁcult to observe a sufﬁcient number of “long-range”
homonuclear 1H-1H NOEs for structure determination of membrane
proteins in micelles or isotropic bicelles. Instead, the measurement of
residue dipolar couplings (RDCs) of weakly aligned samples using an
in-phase/anti-phase (IPAP) experiment [61] provide the principal
orientational restraints [62–64] that are used for structure determi-
nation of membrane proteins. The protein-containing micelle or
isotropic bicelle samples can be weakly aligned by incorporating them
into polyacrylamide gels that are stretched or compressed [65–67], or
by adding intact bacteriophage particles [68], DNA [69] or lanthanide
ions [70,71] to the solutions. Fig. 4 shows plots of experimental 1H-15N
RDCs as a function of residue number for the backbone amide sites of
p7 and Vpu. Dipolar Waves are highly effective at identifying and
characterizing the principal secondary structure features of mem-
brane proteins [62]. Fitting of sine waves with periodicities of 3.6
residues to the RDCs plotted in Fig. 4 demonstrates the presence ofFig. 4. Plots of 1H-15N RDCs as a function of residue number. Left panel: p7. Right panel: Vp
50 °C. The alignment was induced by stressed polyacrylamide gels. Dipolar waves were qua
segments of the proteins.helical regions that encompass residues 9 to 26, 33 to 49 and 57 to 70
in Vpu, and residues 6 to 16, 17 to 27, 41 to 49 and 50 to 57 in p7. The
presence of a break in the dipolar wave is an indicator of a kink in the
helices. Also mobile loops and terminal regions have negligible RDC
values. In addition to describing the secondary structure of the
proteins, these measurements provide input for the calculation of the
three-dimensional structure of a protein, although for this purpose it
is necessary to obtain data from multiple alignment media to
eliminate angular ambiguities.
5. Solid-state NMR
5.1. Solid-state NMR experiments of aligned samples
The protein-containing bilayer samples are carefully checked by 31P
NMR to ensure that the lipid bilayers are uniform andwell aligned in the
magnetic ﬁeld before the initiation of further experiments. Samples
containing p7 or Vpu yield high quality 31P spectra in magneticallyu. The RDCs were measured from weakly aligned protein samples in DHPC micelles at
ntitatively ﬁt to the data. The regions with best ﬁts to a sinusoid determine the helical
Fig. 5. 15N solid-state NMR spectra of uniformly 15N labeled proteins in bilayers aligned
with their normals perpendicular to the magnetic ﬁeld. (A and B) p7. (C and D) Vpu. (A
and C) Experimental spectra obtained at 700 MHz and 42 °C. (B) Simulated spectra of
p7 based on helices tilted 10° and 25° from the bilayer normal. Bottom: (D) Simulated
spectra of Vpu based on helices with tilt angles of 30° (trans-membrane) and 70°
(cytoplasmic).
Fig. 6. Cartoon drawings of p7 and Vpu in bilayers based on the analysis of the dipolar
waves from the solution NMR data and the comparison between the experimental and
simulated spectra from the solid-state NMR data.
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spectra demonstrate that the proteins are well aligned along with the
bilayers. The lack of underlying powder pattern intensity or a
distinguishable isotropic intensity, and observing the bulk of the signal
intensity between 70 ppm and 140 ppm (Fig. 5A and B) indicates that
the proteins assume folded conformations in bilayers alignedwith their
normals perpendicular to the direction of the magnetic ﬁeld.
The chemical shifts of the backbone amides are orientation
dependent because the proteins are not undergoing isotropic
reorientation, and the frequencies of the resonances can be directly
correlated to the tilt angle of the helical segments of the proteins
within the bilayers by comparisonswith simulated spectra. An overlay
of simulated spectra for helices that are tilted 10° and 25° from the
bilayer normal (Fig. 5C) is consistent with the experimental data for
p7. Vpu has one transmembrane helix that is tilted 27° or 30° with
respect to the bilayer normal in DMPC/DMPG bilayers [11] or DMPC/
DHPC bicelles, respectively [12]. The comparison of an experimental
spectrum of full-length Vpu and a simulated spectrum of an ideal
transmembrane helix tilted 30° (80 ppm–110 ppm) and in-plane
helix titled 70° (120 ppm–135 ppm) demonstrates that the orienta-
tion of the cytoplasmic domain in bicelles is similar to that in lipid
bilayers aligned macroscopically on glass slides [6].
6. Conclusions
p7 and Vpu are representative examples of the class of viral
membrane proteins known as viroporins. Their roles in the infectivity
of HCV and HIV-1, respectively, make them potential targets for anti-
viral drugs. The combination of structural and functional studies will
play an important role in the development of new drugs. The
relatively small sizes of these proteins makes them well suited for
studies by NMR spectroscopy. The successful incorporation of these
proteins into micelles, isotropic bicelles, and lipid bilayers and the
optimization of the samples and experimental conditions result in
well-resolved spectra that enable their dynamics and secondary
structures to be characterized.
Although p7 and Vpu are thought to play similar roles in the life
cycles of their respective viruses, they have very different structures
(Fig. 6). The measurement of 1H-15N residual dipolar couplings ofweakly aligned samples by solution NMR, and the subsequent ﬁtting
of dipolar waves to the plots of RDCs as a function of residue number
enabled the secondary structures of the protein to be deﬁned. p7 was
found to have what appears to be two transmembrane segments
between residues 6–27 and 41–57, each of which consists of two
distinct helical segments. In contrast, Vpu has a single transmembrane
helix between residues 9 and 26, and a cytoplasmic domain that
contains two shorter helices between residues 33 and 49 and between
57 and 70 separated by a short ﬂexible loop that contains the
phosphorylation sites essential for one of its biological functions. The
15N solid-state NMR spectra of the proteins in magnetically aligned
bilayer samples provide insights into the structures of the proteins as
well as their arrangements within the bilayers. Comparison of
simulated and experimental NMR spectra for p7 in aligned bilayers
indicates that two of the transmembrane helical segments are tilted
approximately 10° and 25° from the bilayer normal, while for Vpu, a
tilt angle of 30° was observed for the single transmembrane helix.
Considering the mobile N- and C-terminal residues, the inter-helical
loops, and the helical segments, these small membrane proteins have
remarkably complex structures. As the NMR studies proceed toward
completion and atomic resolution, the structural basis for the
biological activities of p7 and Vpu should begin to be revealed.References
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